Mark Shary

Prepare for Meeting →

Managing Partner

Tamarind Hill

Check size: $2M-$7M seed rounds, as published by Tamarind Hill.

Investment Thesis

Mark Shary invests or supports investments through Tamarind Hill's published strategy: Lead seed rounds for B2B healthcare companies with early product-market fit across decentralized care, care economics and healthcare supply-chain innovation.

What Excites Them

Operator-led B2B healthcare teams with early product-market fit where Tamarind Hill's sector network and hands-on commercialization support can be decisive.

What They Pass On

Generalist opportunities, consumer-only healthcare and companies without early product-market-fit evidence or a clear strategic-value fit are less aligned.

How to Pitch

Show the B2B healthcare problem, early product-market-fit evidence, care-cost or supply-chain impact, commercialization plan and why Tamarind Hill can add strategic value.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Mark Shary is a current Managing Partner at Tamarind Hill, according to the firm's official roster. No additional personal background is inferred where the firm does not publish a biography.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal